pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

575 catalysts · 4,970 phase readout · 2,357 8k filing · 287 earnings · 276 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 28 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: earnings×type: filing×type: pdufa×clear all
type
  • phase readout4,970
  • 8k filing2,357
  • earnings287
  • pdufa276
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area
    • Infectious Disease7
    • Ophthalmology5

    Week of Apr 27, 2026

    50
    ›Apr 28, 2026patent expiry91d agoGSK plc — dolutegravir sodium ODT (Constraining Patent Expiry (Japan))dolutegravir sodium

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →dolutegravir sodium →source: globaldata
    ›Apr 28, 2026patent expiry91d agoGSK plc — (abacavir sulfate + dolutegravir sodium+ lamivudine) ODT (Constraining Patent Expiry (Japan))(abacavir sulfate + dolutegravir sodium + lamivudine)

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →(abacavir sulfate + dolutegravir sodium + lamivudine) →source: globaldata
    ›Apr 28, 2026patent expiry91d agoGSK plc — cabotegravir sodium (Constraining Patent Expiry (US))cabotegravir sodium

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir sodium →source: globaldata
    ›Apr 28, 2026patent expiry91d agoViiV Healthcare UK Ltd — cabotegravir + rilpivirine LA (Constraining Patent Expiry (US))cabotegravir + rilpivirine LA

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir + rilpivirine LA →source: globaldata
    ›Apr 28, 2026patent expiry91d agoViiV Healthcare UK Ltd — cabotegravir LA (Constraining Patent Expiry (US))cabotegravir LA

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir LA →source: globaldata
    ›Apr 28, 2026pdufa91d agoMerck & Co Inc — (doravirine + islatravir hydrate) (PDUFA)(doravirine + islatravir hydrate)

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →(doravirine + islatravir hydrate) →source: globaldata
    ›Apr 28, 2026earnings91d agoNOVARTIS AG earningsNOVARTIS AG

    Anticipated earnings call for NOVARTIS AG ($NVS).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings91d agoINCYTE CORP earningsINCYTE CORP

    Anticipated earnings call for INCYTE CORP ($INCY).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings91d agoECOLAB INC. earningsECOLAB INC.

    Anticipated earnings call for ECOLAB INC. ($ECL).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings91d agoOrion Group Holdings Inc earningsOrion Group Holdings Inc

    Anticipated earnings call for Orion Group Holdings Inc ($ORN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026pdufa90d agoSanofi — teplizumab (PDUFA)teplizumab

    Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)

    full page →teplizumab →source: globaldata
    ›Apr 29, 2026earnings90d agoAbbVie Inc. earningsAbbVie Inc.

    Anticipated earnings call for AbbVie Inc. ($ABBV).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoASTRAZENECA PLC earningsASTRAZENECA PLC

    Anticipated earnings call for ASTRAZENECA PLC ($AZN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoGSK plc earningsGSK plc

    Anticipated earnings call for GSK plc ($GSK).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoREGENERON PHARMACEUTICALS, INC. earningsREGENERON PHARMACEUTICALS, INC.

    Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoTEVA PHARMACEUTICAL INDUSTRIES LTD earningsTEVA PHARMACEUTICAL INDUSTRIES LTD

    Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoGLAUKOS Corp earningsGLAUKOS Corp

    Anticipated earnings call for GLAUKOS Corp ($GKOS).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoBIOGEN INC. earningsBIOGEN INC.

    Anticipated earnings call for BIOGEN INC. ($BIIB).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoBausch & Lomb Corp earningsBausch & Lomb Corp

    Anticipated earnings call for Bausch & Lomb Corp ($BLCO).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoSBA COMMUNICATIONS CORP earningsSBA COMMUNICATIONS CORP

    Anticipated earnings call for SBA COMMUNICATIONS CORP ($SBAC).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoAGIOS PHARMACEUTICALS, INC. earningsAGIOS PHARMACEUTICALS, INC.

    Anticipated earnings call for AGIOS PHARMACEUTICALS, INC. ($AGIO).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoIONIS PHARMACEUTICALS INC earningsIONIS PHARMACEUTICALS INC

    Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings90d agoAvantor, Inc. earningsAvantor, Inc.

    Anticipated earnings call for Avantor, Inc. ($AVTR).

    full page →yahoo earnings ↗
    ›Apr 30, 2026patent expiry89d agoBasilea Pharmaceutica Ltd — isavuconazonium sulfate (Constraining Patent Expiry (US))isavuconazonium sulfate

    Therapy area: Infectious Disease. Indication: Aspergillosis, Candidiasis, Cryptococcal Meningitis, Cryptococcosis, Zygomycosis (Mucormycosis)

    full page →isavuconazonium sulfate →source: globaldata
    ›Apr 30, 2026filing89d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing89d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Choroidal Neovascularization

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing89d agoSarepta Therapeutics Inc — golodirsen (NDA/BLA Filing (US))golodirsen

    Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy

    full page →golodirsen →source: globaldata
    ›Apr 30, 2026filing89d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing89d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Diabetic Retinopathy

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing89d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Diabetic Macular Edema

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026pdufa89d agoAxsome Therapeutics Inc — (bupropion hydrochloride + dextromethorphan) ER (PDUFA)(bupropion hydrochloride + dextromethorphan) ER

    Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease

    full page →(bupropion hydrochloride + dextromethorphan) ER →source: globaldata
    ›Apr 30, 2026earnings89d agoMERIT MEDICAL SYSTEMS INC earningsMERIT MEDICAL SYSTEMS INC

    Anticipated earnings call for MERIT MEDICAL SYSTEMS INC ($MMSI).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoMerck & Co., Inc. earningsMerck & Co., Inc.

    Anticipated earnings call for Merck & Co., Inc. ($MRK).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoCARDINAL HEALTH INC earningsCARDINAL HEALTH INC

    Anticipated earnings call for CARDINAL HEALTH INC ($CAH).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoDEXCOM INC earningsDEXCOM INC

    Anticipated earnings call for DEXCOM INC ($DXCM).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoELI LILLY & Co earningsELI LILLY & Co

    Anticipated earnings call for ELI LILLY & Co ($LLY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoSTRYKER CORP earningsSTRYKER CORP

    Anticipated earnings call for STRYKER CORP ($SYK).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoBRISTOL MYERS SQUIBB CO earningsBRISTOL MYERS SQUIBB CO

    Anticipated earnings call for BRISTOL MYERS SQUIBB CO ($BMY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoAMGEN INC earningsAMGEN INC

    Anticipated earnings call for AMGEN INC ($AMGN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoBIOMARIN PHARMACEUTICAL INC earningsBIOMARIN PHARMACEUTICAL INC

    Anticipated earnings call for BIOMARIN PHARMACEUTICAL INC ($BMRN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoBAXTER INTERNATIONAL INC earningsBAXTER INTERNATIONAL INC

    Anticipated earnings call for BAXTER INTERNATIONAL INC ($BAX).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoCORCEPT THERAPEUTICS INC earningsCORCEPT THERAPEUTICS INC

    Anticipated earnings call for CORCEPT THERAPEUTICS INC ($CORT).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoTravere Therapeutics, Inc. earningsTravere Therapeutics, Inc.

    Anticipated earnings call for Travere Therapeutics, Inc. ($TVTX).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoARVINAS, INC. earningsARVINAS, INC.

    Anticipated earnings call for ARVINAS, INC. ($ARVN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoALNYLAM PHARMACEUTICALS, INC. earningsALNYLAM PHARMACEUTICALS, INC.

    Anticipated earnings call for ALNYLAM PHARMACEUTICALS, INC. ($ALNY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoSummit Therapeutics Inc. earningsSummit Therapeutics Inc.

    Anticipated earnings call for Summit Therapeutics Inc. ($SMMT).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoILLUMINA, INC. earningsILLUMINA, INC.

    Anticipated earnings call for ILLUMINA, INC. ($ILMN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoTENET HEALTHCARE CORP earningsTENET HEALTHCARE CORP

    Anticipated earnings call for TENET HEALTHCARE CORP ($THC).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoAscendis Pharma A/S earningsAscendis Pharma A/S

    Anticipated earnings call for Ascendis Pharma A/S ($ASND).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings89d agoSPX Technologies, Inc. earningsSPX Technologies, Inc.

    Anticipated earnings call for SPX Technologies, Inc. ($SPXC).

    full page →yahoo earnings ↗
    ← prev
    page 1 of 12
    next →
    $GSK51.98+1.23%
    $INCY119.14+1.25%
    $ORN12.20-3.86%
    $GSK51.98+1.23%
    $GSK51.98+1.23%
    $NVS156.44+0.92%
    $ECL271.20+0.91%
    $MRK131.40+0.25%
    $ABBV258.52-0.32%
    $SNY44.33+2.26%
    $AZN169.64+0.22%
    $GSK51.98+1.23%
    $REGN672.60+2.53%
    $TEVA31.06+0.81%
    $GKOS151.91-1.09%
    $IONS56.68+0.23%
    $AGIO37.55+3.29%
    $BIIB201.95-0.12%
    $BLCO16.28+0.68%
    $SBAC173.50-0.04%
    $AVTR11.80+3.19%
    $SRPT16.32+4.05%
    $AXSM239.47-0.64%
    $MMSI76.22+2.55%
    $MRK131.40+0.25%
    $CAH229.47+0.63%
    $DXCM73.63+2.91%
    $SYK336.45+1.88%
    $LLY1197.14+0.09%
    $BMY62.69+0.97%
    $AMGN376.98+0.25%
    $BMRN60.85+2.57%
    $BAX23.16+3.39%
    $CORT92.10-3.42%
    $TVTX56.94-0.74%
    $ARVN8.2700+2.99%
    $ALNY283.24+4.22%
    $SMMT13.51-1.13%
    $ILMN189.86-2.18%
    $THC243.36+4.36%
    $ASND253.42-0.17%
    $SPXC216.19-1.76%